Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
This piece clarifies how blockchain tech and Bitcoin relate yet differ, focusing on purpose, structure, and use cases for readers new to crypto.
16,210 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Geopolitical frictions in the Strait of Hormuz push oil prices higher, reshaping risk and opportunity for energy inve...
Wall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
Nuscale Power stock has drawn attention for a potential 195% upside from some analysts. This article breaks down what...
AI-driven demand and memory shortages could propel Micron to new highs by late 2027. This article lays out why a big ...
Marvell Technology tumbles on revised AI capex forecasts, intensifying a wider retreat in semiconductor names. Major ...
When a biotech deal moves a small cap, it can set the tone for the whole sector. This story explains what happened wi...
After a decade of freedom, I look back at the retirement mistakes made and the lessons that kept my finances afloat. ...
Prediction markets tied to the World Cup final surge to record volumes, with Spain favored over Argentina as betting ...
The Metals Company stock faced a sharp pullback in early 2026 after a dramatic rally in the previous year. This artic...
Warren Buffett's looming Berkshire Hathaway exit plans could reshape both philanthropy and investing. This analysis e...
Meta Platforms Looks Abandon a $174B AI bet signals a strategic pivot. This article breaks down what it means for inv...